BayMark Health Services Acquires First Opioid Treatment Program in Utah

Thursday, November 15, 2018 Alcohol & Drug Abuse News
Email Print This Page Comment bookmark
Font : A-A+

BayMark Health Services expands its services into Utah with the acquisition of Metamorphosis, Opioid Treatment Programs in Salt Lake City and Ogden.

LEWISVILLE, Texas, Nov. 15, 2018 /PRNewswire-PRWeb/ -- BayMark Health Services announced the acquisition of Metamorphosis,

an Opioid Treatment Program (OTP) with locations in Salt Lake City and Ogden, Utah earlier this week. Providing medication-assisted treatment since 1995, Metamorphosis has established themselves as a high-quality, trusted provider of evidence-based treatment for opioid addiction. The Metamorphosis programs will become BAART Programs Salt Lake City and BAART Programs Ogden.

"Metamorphosis was founded in 1995 to provide much needed services to the greater Salt Lake City area where there wasn't a large number of options for those seeking medication-assisted treatment for opioid addiction," stated Shannon Terwedo, President of Metamorphosis. "We have worked over the last 20 years to create safe and effective recovery programs for our patients and to educate our community about the benefits of this proven treatment modality. We feel confident that BayMark will continue our mission and maintain the highest levels of care for our patients."

BAART Programs, a BayMark Health Services company, provides outpatient medication-assisted treatment (MAT) for opioid addiction and dependency. Medication-assisted treatment combines medications, such as methadone and buprenorphine, with addiction counseling and behavioral therapies. This approach provides an evidence-based, comprehensive treatment plan, individualized to meet the needs of each patient.

David K. White, Ph.D., Chief Executive Officer of BayMark Health Services, added, "As the opioid epidemic persists, accessibility to proven treatment options for opioid addiction is critical. BayMark has over 50 years of cumulative experience in treating this disease and looks to work with organizations who have established a foundation of quality care and compassion in their practices. Our goal is to build upon the great services offered by Metamorphosis by bringing new and fresh ideas. We look forward to continuing and adding to the legacy established by Metamorphosis!"

For more information on BAART Programs visit: http://www.BAARTPrograms.com.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to more than 46,000 patients in recovery from opioid use disorder. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of prescription pain medication or other opiates. The BayMark continuum of patient-focused services includes highly structured opioid treatment programs utilizing methadone or buprenorphine and office-based buprenorphine programs, both of which incorporate counseling as part of an individualized treatment plan; as well as, ambulatory withdrawal management services with naltrexone therapy, residential treatment and recovery support services.

 

SOURCE BayMark Health Services



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store